Main variables;Main activity, secondary one or a tool necessary for production;Total
Companies that carry out R&D in Biotechnology;Total;1.133
Companies that carry out R&D in Biotechnology;Main;603
Companies that carry out R&D in Biotechnology;Secondary dwellings;173
Companies that carry out R&D in Biotechnology;Tool;357
%Companies according to biotechnology used: Genetic code;Total;33
%Companies according to biotechnology used: Genetic code;Main;39
%Companies according to biotechnology used: Genetic code;Secondary dwellings;28
%Companies according to biotechnology used: Genetic code;Tool;25
%Companies according to biotechnology used: Functional units;Total;41
%Companies according to biotechnology used: Functional units;Main;44
%Companies according to biotechnology used: Functional units;Secondary dwellings;39
%Companies according to biotechnology used: Functional units;Tool;36
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Total;24
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Main;29
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Secondary dwellings;19
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Tool;17
%Companies according to biotechnology used: Bioprocesses;Total;50
%Companies according to biotechnology used: Bioprocesses;Main;45
%Companies according to biotechnology used: Bioprocesses;Secondary dwellings;42
%Companies according to biotechnology used: Bioprocesses;Tool;61
%Companies according to biotechnology used: Sub-cellular organisms;Total;6
%Companies according to biotechnology used: Sub-cellular organisms;Main;8
%Companies according to biotechnology used: Sub-cellular organisms;Secondary dwellings;5
%Companies according to biotechnology used: Sub-cellular organisms;Tool;3
%Companies according to biotechnology used: Bio-computing;Total;24
%Companies according to biotechnology used: Bio-computing;Main;33
%Companies according to biotechnology used: Bio-computing;Secondary dwellings;19
%Companies according to biotechnology used: Bio-computing;Tool;12
%Companies according to biotechnology used: Nanobiotechnology;Total;13
%Companies according to biotechnology used: Nanobiotechnology;Main;17
%Companies according to biotechnology used: Nanobiotechnology;Secondary dwellings;15
%Companies according to biotechnology used: Nanobiotechnology;Tool;6
%Companies according to biotechnology used: Other;Total;14
%Companies according to biotechnology used: Other;Main;16
%Companies according to biotechnology used: Other;Secondary dwellings;16
%Companies according to biotechnology used: Other;Tool;11
%Company by field(s) of ultimate application of biotechnology use: Human Health;Total;45
%Company by field(s) of ultimate application of biotechnology use: Human Health;Main;59
%Company by field(s) of ultimate application of biotechnology use: Human Health;Secondary dwellings;41
%Company by field(s) of ultimate application of biotechnology use: Human Health;Tool;24
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Total;18
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Main;21
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Secondary dwellings;14
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Tool;13
%Company by field(s) of ultimate application of biotechnology use: Food products;Total;31
%Company by field(s) of ultimate application of biotechnology use: Food products;Main;25
%Company by field(s) of ultimate application of biotechnology use: Food products;Secondary dwellings;28
%Company by field(s) of ultimate application of biotechnology use: Food products;Tool;43
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Total;22
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Main;19
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Secondary dwellings;27
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Tool;26
%Company by field(s) of ultimate application of biotechnology use: Environment;Total;14
%Company by field(s) of ultimate application of biotechnology use: Environment;Main;11
%Company by field(s) of ultimate application of biotechnology use: Environment;Secondary dwellings;22
%Company by field(s) of ultimate application of biotechnology use: Environment;Tool;13
%Company by field(s) of ultimate application of biotechnology use: Industry;Total;12
%Company by field(s) of ultimate application of biotechnology use: Industry;Main;13
%Company by field(s) of ultimate application of biotechnology use: Industry;Secondary dwellings;16
%Company by field(s) of ultimate application of biotechnology use: Industry;Tool;8
Personnel in R&D in biotechnology (no. of persons);Total;11.510
Personnel in R&D in biotechnology (no. of persons);Main;6.862
Personnel in R&D in biotechnology (no. of persons);Secondary dwellings;1.521
Personnel in R&D in biotechnology (no. of persons);Tool;3.127
Personnel in R&D in biotechnology (no. of persons): Researchers;Total;6.202
Personnel in R&D in biotechnology (no. of persons): Researchers;Main;3.759
Personnel in R&D in biotechnology (no. of persons): Researchers;Secondary dwellings;900
Personnel in R&D in biotechnology (no. of persons): Researchers;Tool;1.543
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Total;5.308
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Main;3.103
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Secondary dwellings;621
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Tool;1.584
Personnel in R&D in biotechnology (no. of persons): women;Total;6.389
Personnel in R&D in biotechnology (no. of persons): women;Main;4.015
Personnel in R&D in biotechnology (no. of persons): women;Secondary dwellings;750
Personnel in R&D in biotechnology (no. of persons): women;Tool;1.624
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Total;3.304
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Main;2.079
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Secondary dwellings;442
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Tool;783
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Total;3.086
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Main;1.937
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Secondary dwellings;308
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Tool;841
Personnel in R&D in biotechnology (FTE);Total;8.236,9
Personnel in R&D in biotechnology (FTE);Main;5.430,2
Personnel in R&D in biotechnology (FTE);Secondary dwellings;989,7
Personnel in R&D in biotechnology (FTE);Tool;1.817
Personnel in R&D in biotechnology (FTE): Researchers;Total;4.596,1
Personnel in R&D in biotechnology (FTE): Researchers;Main;3.001,4
Personnel in R&D in biotechnology (FTE): Researchers;Secondary dwellings;642,6
Personnel in R&D in biotechnology (FTE): Researchers;Tool;952,1
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Total;3.640,8
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Main;2.428,8
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Secondary dwellings;347,1
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Tool;864,9
Personnel in R&D in biotechnology (FTE): women;Total;4.698,5
Personnel in R&D in biotechnology (FTE): women;Main;3.180,1
Personnel in R&D in biotechnology (FTE): women;Secondary dwellings;503,1
Personnel in R&D in biotechnology (FTE): women;Tool;1.015,3
Personnel in R&D in biotechnology (FTE): (women) Researchers;Total;2.512,5
Personnel in R&D in biotechnology (FTE): (women) Researchers;Main;1.684,7
Personnel in R&D in biotechnology (FTE): (women) Researchers;Secondary dwellings;323,4
Personnel in R&D in biotechnology (FTE): (women) Researchers;Tool;504,4
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Total;2.186
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Main;1.495,4
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Secondary dwellings;179,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Tool;510,9
Internal expenditure on R&D (thousands of euros);Total;769.431
Internal expenditure on R&D (thousands of euros);Main;541.881
Internal expenditure on R&D (thousands of euros);Secondary dwellings;63.951
Internal expenditure on R&D (thousands of euros);Tool;163.599
1) By nature of the expense: Current expenses;Total;719.715
1) By nature of the expense: Current expenses;Main;502.430
1) By nature of the expense: Current expenses;Secondary dwellings;60.603
1) By nature of the expense: Current expenses;Tool;156.683
1.1) Remuneration to researchers;Total;221.447
1.1) Remuneration to researchers;Main;151.282
1.1) Remuneration to researchers;Secondary dwellings;26.154
1.1) Remuneration to researchers;Tool;44.011
1.2) Remuneration to technicians and assistants;Total;122.809
1.2) Remuneration to technicians and assistants;Main;83.753
1.2) Remuneration to technicians and assistants;Secondary dwellings;10.469
1.2) Remuneration to technicians and assistants;Tool;28.587
1.3) Other current expenses;Total;375.459
1.3) Other current expenses;Main;267.396
1.3) Other current expenses;Secondary dwellings;23.979
1.3) Other current expenses;Tool;84.084
2) By nature of the expense: Capital expenses;Total;49.715
2) By nature of the expense: Capital expenses;Main;39.451
2) By nature of the expense: Capital expenses;Secondary dwellings;3.348
2) By nature of the expense: Capital expenses;Tool;6.916
2.1) Land and buildings;Total;9.521
2.1) Land and buildings;Main;7.987
2.1) Land and buildings;Secondary dwellings;676
2.1) Land and buildings;Tool;858
2.2) Equipment and instruments;Total;30.466
2.2) Equipment and instruments;Main;22.742
2.2) Equipment and instruments;Secondary dwellings;2.475
2.2) Equipment and instruments;Tool;5.248
2.3) Acquisition of specific R+D software;Total;1.810
2.3) Acquisition of specific R+D software;Main;1.212
2.3) Acquisition of specific R+D software;Secondary dwellings;89
2.3) Acquisition of specific R+D software;Tool;509
2.4) Otros productos de propiedad intelectual específicos para I+D;Total;7.919
2.4) Otros productos de propiedad intelectual específicos para I+D;Main;7.510
2.4) Otros productos de propiedad intelectual específicos para I+D;Secondary dwellings;108
2.4) Otros productos de propiedad intelectual específicos para I+D;Tool;301
1.1) By origin of the funds: Own funds;Total;490.913
1.1) By origin of the funds: Own funds;Main;347.382
1.1) By origin of the funds: Own funds;Secondary dwellings;40.321
1.1) By origin of the funds: Own funds;Tool;103.210
1.2) By origin of the funds: From companies;Total;82.548
1.2) By origin of the funds: From companies;Main;62.516
1.2) By origin of the funds: From companies;Secondary dwellings;5.356
1.2) By origin of the funds: From companies;Tool;14.676
1.3) By origin of the funds: Public Administration funds;Total;96.809
1.3) By origin of the funds: Public Administration funds;Main;67.645
1.3) By origin of the funds: Public Administration funds;Secondary dwellings;12.905
1.3) By origin of the funds: Public Administration funds;Tool;16.259
1.4) By origin of the funds: From Universities;Total;197
1.4) By origin of the funds: From Universities;Main;193
1.4) By origin of the funds: From Universities;Secondary dwellings;0
1.4) By origin of the funds: From Universities;Tool;4
1.5) By origin of the funds: From non profit private institutions;Total;4.766
1.5) By origin of the funds: From non profit private institutions;Main;1.422
1.5) By origin of the funds: From non profit private institutions;Secondary dwellings;0
1.5) By origin of the funds: From non profit private institutions;Tool;3.344
1.6) By origin of the funds: Foreign funds;Total;94.197
1.6) By origin of the funds: Foreign funds;Main;62.723
1.6) By origin of the funds: Foreign funds;Secondary dwellings;5.369
1.6) By origin of the funds: Foreign funds;Tool;26.106
Purchase of R&D services in biotechnology (thousands of euros);Total;120.281
Purchase of R&D services in biotechnology (thousands of euros);Main;102.804
Purchase of R&D services in biotechnology (thousands of euros);Secondary dwellings;9.714
Purchase of R&D services in biotechnology (thousands of euros);Tool;7.763
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Total;69.564
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Main;57.335
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Secondary dwellings;8.455
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Tool;3.773
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Total;50.718
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Main;45.469
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Secondary dwellings;1.259
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Tool;3.990
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Total;45
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Main;52
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Secondary dwellings;42
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Tool;35
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Total;12
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Main;9
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Secondary dwellings;17
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Tool;16
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Total;16
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Main;14
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Secondary dwellings;20
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Tool;18
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Total;14
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Main;14
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Secondary dwellings;16
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Tool;12
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Total;16
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Main;16
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Secondary dwellings;20
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets;Tool;14
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Total;18
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Main;20
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Secondary dwellings;18
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels;Tool;16
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Total;15
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Main;15
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Secondary dwellings;18
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception;Tool;15
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Total;37
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Main;39
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Secondary dwellings;38
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Tool;32
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Total;52
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Main;54
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Secondary dwellings;56
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost;Tool;46
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Total;20
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Main;20
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Secondary dwellings;21
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Tool;20
% Companies that have requested biotechnology patents;Total;15
% Companies that have requested biotechnology patents;Main;21
% Companies that have requested biotechnology patents;Secondary dwellings;11
% Companies that have requested biotechnology patents;Tool;7
Number of patents requested;Total;681
Number of patents requested;Main;485
Number of patents requested;Secondary dwellings;100
Number of patents requested;Tool;96
% Companies with income of an international origin related to biotechnological activities;Total;24,3
% Companies with income of an international origin related to biotechnological activities;Main;34,1
% Companies with income of an international origin related to biotechnological activities;Secondary dwellings;12,6
% Companies with income of an international origin related to biotechnological activities;Tool;13,5
% Turnover representing income of an international origin related to biotechnological activities;Total;1
% Turnover representing income of an international origin related to biotechnological activities;Main;9
% Turnover representing income of an international origin related to biotechnological activities;Secondary dwellings;0
% Turnover representing income of an international origin related to biotechnological activities;Tool;1
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Total;59,6
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Main;60,2
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Secondary dwellings;79,3
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU;Tool;54,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Total;40,4
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Main;39,8
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Secondary dwellings;20,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries;Tool;45,4
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Total;80,4
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Main;78,5
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Secondary dwellings;17,9
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Tool;96,8
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Total;16,5
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Main;19,3
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Secondary dwellings;0,6
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Tool;1,4
% Income of an international origin related with activities according to the classification: Operating source abroad;Total;2,2
% Income of an international origin related with activities according to the classification: Operating source abroad;Main;1,3
% Income of an international origin related with activities according to the classification: Operating source abroad;Secondary dwellings;70,4
% Income of an international origin related with activities according to the classification: Operating source abroad;Tool;1,8
% Income of an international origin related with activities according to the classification: Other;Total;0,9
% Income of an international origin related with activities according to the classification: Other;Main;0,9
% Income of an international origin related with activities according to the classification: Other;Secondary dwellings;11,1
% Income of an international origin related with activities according to the classification: Other;Tool;0